372 related articles for article (PubMed ID: 37996893)
1. A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS.
Awonuga AO; Camp OG; Abu-Soud HM
Reprod Biol Endocrinol; 2023 Nov; 21(1):111. PubMed ID: 37996893
[TBL] [Abstract][Full Text] [Related]
2. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
[TBL] [Abstract][Full Text] [Related]
3. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
[TBL] [Abstract][Full Text] [Related]
4. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
[TBL] [Abstract][Full Text] [Related]
5. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
6. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
[TBL] [Abstract][Full Text] [Related]
7. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
Blank SK; McCartney CR; Marshall JC
Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
[TBL] [Abstract][Full Text] [Related]
8. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
Siddiqui S; Mateen S; Ahmad R; Moin S
J Assist Reprod Genet; 2022 Nov; 39(11):2439-2473. PubMed ID: 36190593
[TBL] [Abstract][Full Text] [Related]
9. Impaired Arginine Metabolism Coupled to a Defective Redox Conduit Contributes to Low Plasma Nitric Oxide in Polycystic Ovary Syndrome.
Krishna MB; Joseph A; Thomas PL; Dsilva B; Pillai SM; Laloraya M
Cell Physiol Biochem; 2017; 43(5):1880-1892. PubMed ID: 29055959
[TBL] [Abstract][Full Text] [Related]
10. Intake of vinegar beverage is associated with restoration of ovulatory function in women with polycystic ovary syndrome.
Wu D; Kimura F; Takashima A; Shimizu Y; Takebayashi A; Kita N; Zhang G; Murakami T
Tohoku J Exp Med; 2013 May; 230(1):17-23. PubMed ID: 23666047
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
12. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
13. The role of AMH in anovulation associated with PCOS: a hypothesis.
Homburg R; Crawford G
Hum Reprod; 2014 Jun; 29(6):1117-21. PubMed ID: 24770999
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
[TBL] [Abstract][Full Text] [Related]
15. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
[TBL] [Abstract][Full Text] [Related]
16. New approach to polycystic ovary syndrome and other forms of anovulatory infertility.
Laven JS; Imani B; Eijkemans MJ; Fauser BC
Obstet Gynecol Surv; 2002 Nov; 57(11):755-67. PubMed ID: 12447098
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound Characterization of Disordered Antral Follicle Development in Women with Polycystic Ovary Syndrome.
Jarrett BY; Vanden Brink H; Oldfield AL; Lujan ME
J Clin Endocrinol Metab; 2020 Nov; 105(11):e3847-61. PubMed ID: 32785651
[TBL] [Abstract][Full Text] [Related]
18. Immune regulation in polycystic ovary syndrome.
Luan YY; Zhang L; Peng YQ; Li YY; Liu RX; Yin CH
Clin Chim Acta; 2022 Jun; 531():265-272. PubMed ID: 35447143
[TBL] [Abstract][Full Text] [Related]
19. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
[TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor yellow A exerts beneficial effects by restoring hormone secretion and alleviating oxidative stress in polycystic ovary syndrome mice.
Luo M; Huang JC; Yang ZQ; Wang YS; Guo B; Yue ZP
Exp Physiol; 2020 Feb; 105(2):282-292. PubMed ID: 31803965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
